Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 1, 2010, Pages 43-49

  Lyakhovitsky, A ^a   Barzilai, A ^a   Heyman, R ^a   Baum, S ^a   Amichai, B ^a   Solomon, M ^a   Shpiro, D ^a   Trau, H ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Atopic dermatitis (AD); Corticosteroids (CS); DLQI (Dermatology Quality of Life Index); Methotrexate (MTX); SCORAD (SCORing Atopic Dermatitis) index

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CYCLOSPORIN; FOLIC ACID; LIVER ENZYME; METHOTREXATE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MALE; NAUSEA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; SKIN BIOPSY; TOPICAL TREATMENT; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 71949084180     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03351.x     Document Type: Article

References (27)

1. Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000 25 (7 522 529.
2. Bannister MJ, Freeman S. Adult-onset atopic dermatitis. Australas J Dermatol 2000 41 (4 225 228.
3. Emerson RM, Williams HC, Allen BR. What is the cost of atopic dermatitis in preschool children? Br J Dermatol 2001 144 (3 514 522.
4. Callen J, Chamlin S, Eichenfield LF et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol 2007 156 (2 203 221.
5. Goujon C, Bérard F, Dahel K, A et al. Methotrexate for the treatment of adult atopic dermatitis. Eur J Dermatol 2006 16 (2 155 158.
6. Weatherhead SC, Wahie S, Reynolds NJ et al. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol 2007 156 (2 346 351.
7. Balasubramaniam P, Ilchyshyn A. Successful treatment of severe atopic dermatitis with methotrexate. Clin Exp Dermatol 2005 30 (4 436 437.
8. Zoller L, Ramon M, Bergman R. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema. Isr Med Assoc J 2008 10 (6 413 414.
9. Egan CA, Rallis TM, Meadows KP et al. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol 1999 40 (4 612 614.
10. Shaffrali FC, Colver GB, Messenger AG et al. Experience with low- dose methotrexate for the treatment of eczema in the elderly. J Am Acad Dermatol 2003 48 (3 417 419.
11. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980 92 : 44 47.
12. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on atopic dermatitis. Dermatology 1993 186 (1 23 31.
13. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994 19 (3 210 216.
14. Ellis C, Luger T, Abeck D et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003 148 (Suppl. 63 3 10.
15. Meduri NB, Vandergriff T, Rasmussen H et al. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed 2007 23 (4 106 112.
16. Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2007 21 (5 606 619.
17. Meggitt SJ, Reynolds NJ. Azathioprine for atopic dermatitis. Clin Exp Dermatol 2001 26 (5 369 375.
18. Murray ML, Cohen JB. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Clin Exp Dermatol 2007 32 (1 23 27.
19. Kuijpers AL, van de Kerkhof PC. Risk-benefit assessment of methotrexate in the treatment of severe psoriasis. Am J Clin Dermatol 2000 1 (1 27 39.
20. Cronstein BN. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 2005 57 (2 163 172.
21. Comet R, Domingo C, Larrosa M et al. Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double blind, randomized, placebo- controlled study. Respir Med 2006 100 (3 411 419.
22. Genestier L, Paillot R, Fournel S et al. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral. T Cells J Clin Invest 1998 102 (2 322 328.
23. Morabito L, Montesinos MC, Schreibman DM et al. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 1998 101 (2 295 300.
24. Bateman EA, Ardern-Jones M, Ogg GS. Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate. Br J Dermatol 2007 156 (6 1376 1377.
25. Berth-Jones J. Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996 135 (Suppl. 48 25 30.
26. Sidbury R, Hanifin JM. Old, new, and emerging therapies for atopic dermatitis. Dermatol Clin 2000 18 (1 1 11.
27. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol 2003 120 (6 932 941.